This ETF provides targeted exposure to small- and mid-cap U.S. healthcare companies focused on innovation, including biotech, pharmaceuticals, and medical technology. Investors use BTEC to gain diversified access to high-growth potential healthcare disruptors without single-stock risk. The fund's niche focus makes it a tactical tool for sector rotation strategies.
1 member of Congress has disclosed 2 trades in Principal Healthcare Innovators ETF (BTEC), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-11-14 | Dwight Evans | sell | $1K – $15K |
| 2021-11-02 | Dwight Evans | buy | $1K – $15K |